Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Segment Information (Details)

v3.20.2
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Net revenues - External $ 2,069,019 $ 4,061,189 $ 3,910,550 $ 9,251,839  
Net income (loss) from continuing operations before income taxes 2,105,455 (13,279,576) (4,765,033) (26,212,371)  
Depreciation and amortization 181,091 186,236 345,798 409,822  
Capital expenditures 10,435 1,398 10,435 43,715  
Total assets 15,215,256   15,215,256   $ 14,707,659
Hospital Operations [Member]          
Net revenues - External 2,069,019 4,055,774 3,909,110 9,161,039  
Net income (loss) from continuing operations before income taxes (2,323,338) (4,002,213) (5,416,271) (7,177,320)  
Depreciation and amortization 176,998 176,371 359,313 350,147  
Capital expenditures 10,435 1,398 10,435 43,715  
Total assets 12,813,219   12,813,219   14,275,256
Clinical Laboratory Operations [Member]          
Net revenues - External 5,415 1,440 90,800  
Net income (loss) from continuing operations before income taxes (293,456) (180,028) (406,842) (405,558)  
Depreciation and amortization 4,041 9,683 (13,702) 59,345  
Total assets 450,212   450,212   330,381
Corporate [Member]          
Net income (loss) from continuing operations before income taxes (696,510) (914,074) (1,342,376) (1,986,909)  
Depreciation and amortization 52 182 187 330  
Total assets 4,457,937   4,457,937   2,305,380
Other Income (Expense), Net [Member]          
Net income (loss) from continuing operations before income taxes 5,418,759 (8,183,261) 2,400,456 (16,642,584)  
Benefit from Income Taxes [Member]          
Net income (loss) from continuing operations before income taxes 1,118,485  
Assets of AMSG and HTS Classified as Held for Sale [Member]          
Total assets 212,018   212,018   514,772
Eliminations [Member]          
Total assets $ (2,718,130)   $ (2,718,130)   $ (2,718,130)